REVELATION BIOSCIENCES, INC.

REVB ·Healthcare, Drug Manufacturers - General, United States
Financial Statements SEC Filings

SEC Filings

Form Filed Description
4 Apr 18, 2023 FORM 4 SUBMISSION
4 Apr 18, 2023 FORM 4 SUBMISSION
8-K Apr 3, 2023 8-K
10-K Mar 30, 2023 10-K
4 Feb 28, 2023 FORM 4 SUBMISSION
4 Feb 28, 2023 FORM 4 SUBMISSION
SC 13G Feb 21, 2023
SC 13G Feb 21, 2023 SCHEDULE 13G
8-K Feb 17, 2023 8-K
SC 13G Feb 14, 2023 SCHEDULE 13G
5 Feb 14, 2023 PRIMARY DOCUMENT
8-K Feb 13, 2023 8-K
424B3 Feb 13, 2023 PROSPECTUS
EFFECT Feb 9, 2023
S-1MEF Feb 9, 2023 REGISTRATION STATEMENT
S-1/A Feb 9, 2023 AMENDMENT NO. 2 TO FORM S-1
SC 13G/A Feb 6, 2023
CORRESP Feb 6, 2023
CORRESP Feb 1, 2023
S-1/A Feb 1, 2023 AMENDMENT NO. 1 TO FORM S-1
8-K Jan 31, 2023 8-K
SC 13G/A Jan 31, 2023 SC 13G/A
DEFA14A Jan 13, 2023 DEFA14A
25-NSE Jan 13, 2023
8-K Jan 10, 2023 8-K
← Newer Page 9 of 16 · 387 filings Older →